| Date Filed | Type | Description |
| 07/14/2023 |
4
| Carrick Sean (President & CEO) has filed a Form 4 on Nascent Biotech Inc.|
Txns:
| Gifted 960,000 shares
@ $0.05, valued at
$48k
|
|
| 07/13/2023 |
4
| HOLDEN LOWELL THOMAS (CFO) has filed a Form 4 on Nascent Biotech Inc.|
Txns:
| Gifted 700,000 shares
@ $0.049, valued at
$34.3k
|
|
| 06/09/2023 |
4
| Karas Douglas John (Director) has filed a Form 4 on Nascent Biotech Inc.|
Txns:
| Acquired 89,285 shares
@ $0.06, valued at
$5.4k
|
|
| 06/09/2023 |
4
| HOLDEN LOWELL THOMAS (CFO) has filed a Form 4 on Nascent Biotech Inc.|
Txns:
| Acquired 581,000 shares
@ $0.06, valued at
$34.9k
Bought 130,000 shares
@ $0.04, valued at
$5.2k
|
|
| 06/09/2023 |
4
| Carrick Sean (President & CEO) has filed a Form 4 on Nascent Biotech Inc.|
Txns:
| Acquired 1,167,000 shares
@ $0.06, valued at
$70k
|
|
| 02/14/2023 |
4
| HOLDEN LOWELL THOMAS (CFO) has filed a Form 4 on Nascent Biotech Inc.|
Txns:
| Gifted 700,000 shares
@ $0.12, valued at
$84k
|
|
| 02/02/2023 |
4
| HOLDEN LOWELL THOMAS (CFO) has filed a Form 4 on Nascent Biotech Inc.|
Txns:
| Bought 20,000 shares
@ $0.14, valued at
$2.8k
|
|
| 02/02/2023 |
4
| HOLDEN LOWELL THOMAS (CFO) has filed a Form 4 on Nascent Biotech Inc.|
Txns:
| Bought 20,000 shares
@ $0.14, valued at
$2.8k
|
|
| 01/03/2023 |
4
| Karas Douglas John (Director) has filed a Form 4 on Nascent Biotech Inc.|
Txns:
| Acquired 25,000 shares
@ $0.2, valued at
$5k
|
|
| 01/03/2023 |
4
| HOLDEN LOWELL THOMAS (CFO) has filed a Form 4 on Nascent Biotech Inc.|
Txns:
| Granted 231,000 shares
@ $0.2, valued at
$46.2k
|
|
| 01/03/2023 |
4
| Carrick Sean (President & CEO) has filed a Form 4 on Nascent Biotech Inc.|
Txns:
| Acquired 462,000 shares
@ $0.2, valued at
$92.4k
|
|
| 07/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/19/2022 |
4
| HOLDEN LOWELL THOMAS (CFO) has filed a Form 4 on Nascent Biotech Inc.|
Txns:
| Gifted 700,000 shares
@ $0.08, valued at
$56k
|
|
| 04/04/2022 |
4
| Karas Douglas John (Director) has filed a Form 4 on Nascent Biotech Inc.|
Txns:
| Acquired 300,000 shares
@ $0.05, valued at
$15k
|
|
| 04/04/2022 |
4
| HOLDEN LOWELL THOMAS (CFO) has filed a Form 4 on Nascent Biotech Inc.|
Txns:
| Acquired 1,100,000 shares
@ $0.05, valued at
$55k
Acquired 215,000 shares
@ $0.056, valued at
$12k
|
|
| 04/04/2022 |
4
| Carrick Sean (President & CEO) has filed a Form 4 on Nascent Biotech Inc.|
Txns:
| Acquired 1,000,000 shares
@ $0.05, valued at
$50k
Acquired 430,000 shares
@ $0.056, valued at
$24.1k
|
|
| 02/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/08/2022 |
4
| Carrick Sean (President & CEO) has filed a Form 4 on Nascent Biotech Inc.|
Txns:
| Acquired 347,400 shares
@ $0.105, valued at
$36.5k
|
|
| 08/20/2021 |
4
| HOLDEN LOWELL THOMAS (CFO) has filed a Form 4 on Nascent Biotech Inc.|
Txns:
| Disposed of 700,000 shares
@ $0.105, valued at
$73.5k
Acquired 173,700 shares
@ $0.061, valued at
$10.6k
|
|
| 08/20/2021 |
4
| Carrick Sean (President & CEO) has filed a Form 4 on Nascent Biotech Inc.|
Txns:
| Acquired 347,400 shares
@ $0.105, valued at
$36.5k
|
|
| 08/20/2021 |
4
| Karas Douglas John (Director) has filed a Form 4 on Nascent Biotech Inc.|
Txns:
| Acquired 307,010 shares
@ $0.076, valued at
$23.3k
Acquired 83,334 shares
@ $0.105, valued at
$8.8k
|
|
| 04/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/06/2021 |
4
| Carrick Sean (President & CEO) has filed a Form 4 on Nascent Biotech Inc.|
Txns:
| Acquired 1,250,000 shares
@ $0.06, valued at
$75k
Acquired 1,620,000 shares
@ $0.061, valued at
$98.8k
|
|
| 04/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/11/2021 |
4
| Karas Douglas John (Director) has filed a Form 4 on Nascent Biotech Inc.|
Txns:
| Acquired 71,430 shares
@ $0.07, valued at
$5k
Acquired 350,000 shares
@ $0.05, valued at
$17.5k
Acquired 108,460 shares
@ $0.046, valued at
$5k
|
|
| 01/11/2021 |
4
| HOLDEN LOWELL THOMAS (CFO) has filed a Form 4 on Nascent Biotech Inc.|
Txns:
| Acquired 127,970 shares
@ $0.07, valued at
$9k
Acquired 1,442,000 shares
@ $0.0461, valued at
$66.5k
|
|
| 01/11/2021 |
4
| Carrick Sean (President & CEO) has filed a Form 4 on Nascent Biotech Inc.|
Txns:
| Acquired 218,715 shares
@ $0.1, valued at
$21.9k
Acquired 2,884,000 shares
@ $0.0461, valued at
$133k
|
|
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/03/2020 |
4
| Carrick Sean (President & CEO) has filed a Form 4 on Nascent Biotech Inc.|
Txns:
| Acquired 441,930 shares
@ $0.13, valued at
$57.5k
|
|
| 04/03/2020 |
4
| HOLDEN LOWELL THOMAS (CFO) has filed a Form 4 on Nascent Biotech Inc.|
Txns:
| Acquired 265,160 shares
@ $0.13, valued at
$34.5k
Acquired 265,160 shares
@ $0.13, valued at
$34.5k
|
|
| 04/03/2020 |
4
| Price Brandon (Exec VP Business Development) has filed a Form 4 on Nascent Biotech Inc.|
Txns:
| Acquired 265,160 shares
@ $0.13, valued at
$34.5k
|
|
|